GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Nir Peled, Roni Gillis, Saadettin Kilickap, Patrizia Froesch, Sergei Orlov, Elena Filippova, Umut Demirci, Petros Christopoulos, Irfan Cicin, Fatma Bugdayci Basal, Cengiz Yilmaz, Moiseenko Fedor, Taner Korkmaz, Semra Paydas, Oliver Gautschi, Alisan Zirtiloglu, Yesim Eralp, Havva Yesil Cinkir, Ahmet Sezer, Mustafa ErmanDeniz Tural, Hande Turna, Julien Mazieres, Elizabeth Dudnik, Noemi Reguart, David Ross Camidge, Terry L. Ng, Filiz Çay Şenler, İsmail Beypınar, Doğan Yazılıtaş, Ahmet Demirkazık, Aziz Karaoğlu, Kerem Okutur, Hasan Şenol Coşkun, Mehmet Ali Nahit Şendur, Abdurrahman Isikdogan, Devrim Cabuk, Perran Fulden Yumuk, Ibrahim Yıldız, M. Ali Kaplan, Özgür Özyılkan, İlhan Öztop, Omer Fatih Olmez, Kübra Aydin, Adnan Aydıner, Nezih Meydan, Roxana Denisa Grinberg, Laila C. Roisman

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science